|
1
|
Gluckman E, Rocha V, Boyer-Chammard A,
Locatelli F, Arcese W, Pasquini R, Ortega J, Souillet G, Ferreira
E, Laporte JP, et al: Outcome of cord-blood transplantation from
related and unrelated donors. Eurocord Transplant Group and the
European Blood and Marrow Transplantation Group. N Engl J Med.
337:373–381. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Laughlin MJ, Eapen M, Rubinstein P, Wagner
JE, Zhang MJ, Champlin RE, Stevens C, Barker JN, Gale RP, Lazarus
HM, et al: Outcomes after transplantation of cord blood or bone
marrow from unrelated donors in adults with leukemia. N Engl J Med.
351:2265–2275. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wagner JE, Barker JN, De For TE, Baker KS,
Blazar BR, Eide C, Goldman A, Kersey J, Krivit W, MacMillan ML, et
al: Transplantation of unrelated donor umbilical cord blood in 102
patients with malignant and nonmalignant diseases: Influence of
CD34 cell dose and HLA disparity on treatment-related mortality and
survival. Blood. 100:1611–1618. 2002.PubMed/NCBI
|
|
4
|
Page KM, Zhang L, Mendizabal A, Wease S,
Carter S, Gentry T, Balber AE and Kurtzberg J: Total colony-forming
units are a strong, independent predictor of neutrophil and
platelet engraftment after unrelated umbilical cord blood
transplantation: A single-center analysis of 435 cord blood
transplants. Biol Blood Marrow Transplant. 17:1362–1374. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Broxmeyer HE, Srour EF, Hangoc G, Cooper
S, Anderson SA and Bodine DM: High-efficiency recovery of
functional hematopoietic progenitor and stem cells from human cord
blood cryopreserved for 15 years. Proc Natl Acad Sci USA.
100:645–650. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kudo Y, Minegishi M, Seki O, Takahashi H,
Suzuki A, Narita A, Sato Y, Abe M, Ishioka N, Harigae H and
Tsuchiya S: Quality assessment of umbilical cord blood units at the
time of transplantation. Int J Hematol. 93:645–651. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rodríguez L, García J and Querol S:
Predictive utility of the attached segment in the quality control
of a cord blood graft. Biol Blood Marrow Transplant. 11:247–251.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Storms RW, Trujillo AP, Springer JB, Shah
L, Colvin OM, Ludeman SM and Smith C: Isolation of primitive human
hematopoietic progenitors on the basis of aldehyde dehydrogenase
activity. Proc Natl Acad Sci USA. 96:9118–9123. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Storms RW, Green PD, Safford KM,
Niedzwiecki D, Cogle CR, Colvin OM, Chao NJ, Rice HE and Smith CA:
Distinct hematopoietic progenitor compartments are delineated by
the expression of aldehyde dehydrogenase and CD34. Blood.
106:95–102. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fallon P, Gentry T, Balber AE, Boulware D,
Janssen WE, Smilee R, Storms RW and Smith C: Mobilized peripheral
blood SSCloALDHbr cells have the phenotypic and functional
properties of primitive haematopoietic cells and their number
correlates with engraftment following autologous transplantation.
Br J Haematol. 122:99–108. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee HR, Shin S, Yoon JH, Roh EY, Kim BJ
and Song EY: Aldehyde dehydrogenase-bright cells correlated with
the colony-forming unit-granulocyte-macrophage assay of thawed cord
blood units. Transfusion. 54:1871–1875. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Makino S, Harada M, Akashi K, Taniguchi S,
Shibuya T, Inaba S and Niho Y: A simplified method for
cryopreservation of peripheral blood stem cells at −80 degrees C
without rate-controlled freezing. Bone Marrow Transplant.
8:239–244. 1991.PubMed/NCBI
|
|
13
|
Keeney M, Chin-Yee I, Weir K, Popma J,
Nayar R and Sutherland DR: Single platform flow cytometric absolute
CD34+ cell counts based on the ISHAGE guidelines.
International Society of Hematotherapy and Graft Engineering.
Cytometry. 34:61–70. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fujimori Y, Hara H and Nagai K: Effect of
lymphokine-activated killer cell fraction on the development of
human hematopoietic progenitor cells. Cancer Res. 48:534–538.
1988.PubMed/NCBI
|
|
15
|
Fu SQ, Abboud CN, Brennan JK,
Ifthikharuddin JJ, Nichols D and Liesveld JL: Impact of mobilized
blood progenitor cell quality determined by the CFU-GM/CD34+ ratio
on rapid engraftment after blood stem cell transplantation. Blood
Cells Mol Dis. 28:315–321. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee HR, Shin S, Yoon JH, Roh EY, Song EY,
Han KS and Kim BJ: Attached segment has higher CD34+ cells and
CFU-GM than the main bag after thawing. Cell Transplant.
24:305–310. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shoulars K, Noldner P, Troy JD, Cheatham
L, Parrish A, Page K, Gentry T, Balber AE and Kurtzberg J:
Development and validation of a rapid, aldehyde dehydrogenase
bright-based cord blood potency assay. Blood. 127:2346–2354. 2016.
View Article : Google Scholar : PubMed/NCBI
|
